NDC 55648-986-01 - CEFOTAXIME
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 55648-986
- Requested NDC
- 55648-986-01
- Package NDCs from labels
- 55648-986-01, 55648-986-02, 55648-986-03, 55648-986-04
- Manufacturer
- WOCKHARDT LIMITED
- Effective date
- 2010-10-19
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| CEFOTAXIME - WOCKHARDT LIMITED | WOCKHARDT LIMITED | 2010-10-19 | HUMAN PRESCRIPTION DRUG LABEL |
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 55648-986-01 | CEFOTAXIME | 1 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 1 | 1 | |
| 55648-986-01 | CEFOTAXIME | 10 mL in 1 VIAL, SINGLE-DOSE | INJECTION, POWDER, FOR SOLUTION | 10 | 1 | |
| 55648-986-02 | CEFOTAXIME | 10 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 10 | 1 | |
| 55648-986-03 | CEFOTAXIME | 25 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 25 | 1 | |
| 55648-986-04 | CEFOTAXIME | 50 in 1 CARTON | INJECTION, POWDER, FOR SOLUTION | 50 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| CEFOTAXIME SODIUM | ACTIVE INGREDIENT | 258J72S7TZ | CEFOTAXIME INJECTION, POWDER, FOR SOLUTION [WOCKHARDT LIMITED] | 1 | |
| CEFOTAXIME | ACTIVE MOIETY | N2GI8B1GK7 | CEFOTAXIME INJECTION, POWDER, FOR SOLUTION [WOCKHARDT LIMITED] | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Cefotaxime | CEFOTAXIME INJECTION | SteriMax Inc. | 8efe3bd0-c43a-2bd6-e053-2a95a90a92fa | 2026-06-15 | 1656313 1656318 258J72S7TZ | |
| Cefotaxime | CEFOTAXIME | Hikma Pharmaceuticals USA Inc. | ed23b6bc-32c7-4c50-a53d-313ae78e5623 | 2024-04-11 | Warnings, Adverse reactions | 309068 1656313 1656318 258J72S7TZ |
| Cefotaxime | CEFOTAXIME | Hikma Pharmaceuticals USA Inc. | ef1a6dc6-bc3d-4f09-8f92-7ff328f56561 | 2024-04-11 | Warnings, Adverse reactions | 258J72S7TZ |
| ae6f86a8-6a5c-4c3a-a8cb-aee20b427b5b | a401a44e-2c5c-4c4a-81d8-56a3ef9d57f7 | 2010-10-19 | Warnings, Adverse reactions | ae6f86a8-6a5c-4c3a-a8cb-aee20b427b5b a401a44e-2c5c-4c4a-81d8-56a3ef9d57f7 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.